Skip to content

Phreesia PHR Amortization of deferred commissions

Amortization of deferred commissions at other companies

Evolent Health, Inc. logo
Evolent Health, Inc.EVH
$931K-24.7%
SoundHound AI, Inc. logo
SoundHound AI, Inc.SOUN
$538K
Global Payments logo
Global PaymentsGPN
$24.82M-27.9%

Other financials

Income statement

See full
Revenue$130.9M+12.9%
Gross profit$113.3M+14.1%
Operating income$6.7M+305%
Net income$3.0M+176%
EPS (diluted)$0.05+171%

Balance sheet

See full
Cash & equivalents$73.8M-12.3%
Total debt$98.3M+242%
Total equity$359.1M+27.3%
Total assets$666.1M+66.4%

Cash flow

See full
Operating cash flow$23.9M+61.1%
CapEx$4.3M+23.0%
Free cash flow$19.6M+72.9%

Valuation

See full
Market cap$564.34M-63.8%
P/E61.5×
P/S1.1×-2.5×

Profitability

See full
Gross margin85.4%+0.8pp
Operating margin0.7%+0.4pp
Net margin1.9%+1.0pp
FCF margin15.3%+6.9pp

Returns & leverage

See full
Return on equity2.9%+1.5pp
Debt / equity0.3×+0.2×
Current ratio1.8×-0.2×

Where this comes from

Reported directly by Phreesia in its filing.

Tagged under the XBRL concept us-gaap:CapitalizedContractCostAmortization.

The official record: Phreesia’s 10-Q, filed May 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Phreesia's amortization of deferred commissions.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Phreesia's amortization of deferred commissions?
Phreesia (PHR) reported amortization of deferred commissions of $116K in Q1 2026.
How has Phreesia's amortization of deferred commissions changed year-over-year?
Phreesia's amortization of deferred commissions increased by 5.5% year-over-year, from $110K to $116K.
What is the long-term trend for Phreesia's amortization of deferred commissions?
Over 4 years (2022 to 2026), Phreesia's amortization of deferred commissions has grown at a -28.7% compound annual growth rate (CAGR), from $2.21M to $570K.
What does amortization of deferred commissions mean?
Represents the non-cash expense recognized as capitalized sales commissions are amortized over the expected period of benefit for customer contracts. This metric aligns with ASC 340-40 and reflects the systematic recognition of acquisition costs incurred to secure new business.